Loading...

DRI Healthcare Trust

DHT-UN.TOTSX
Healthcare
Drug Manufacturers - Specialty & Generic
$16.92
$0.04(0.24%)
Canadian Market opens in NaNh NaNm

DRI Healthcare Trust (DHT-UN.TO) Stock Competitors & Peer Comparison

See (DHT-UN.TO) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
DHT-UN.TOCA$16.92+0.24%636.3M-13.54-CA$1.25+1.79%
CURA.TOCA$5.24+25.66%4.1B-11.91-CA$0.44N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$7.79-0.51%2.9B13.43CA$0.58N/A
GTII.CNCA$10.81+11.44%2.5B16.38CA$0.66N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
TRUL.CNCA$11.15+16.88%1.9B-14.19-CA$0.80N/A
CRON.TOCA$3.84+2.40%1.5B-128.00-CA$0.03N/A
TLRY.TOCA$10.82+14.62%1.3B-0.54-CA$20.09N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

DHT-UN.TO vs CURA.TO Comparison April 2026

DHT-UN.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DHT-UN.TO stands at 636.3M. In comparison, CURA.TO has a market cap of 4.1B. Regarding current trading prices, DHT-UN.TO is priced at CA$16.92, while CURA.TO trades at CA$5.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DHT-UN.TO currently has a P/E ratio of -13.54, whereas CURA.TO's P/E ratio is -11.91. In terms of profitability, DHT-UN.TO's ROE is -0.11%, compared to CURA.TO's ROE of -0.30%. Regarding short-term risk, DHT-UN.TO is less volatile compared to CURA.TO. This indicates potentially lower risk in terms of short-term price fluctuations for DHT-UN.TO.Check CURA.TO's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions